Latest News
The Latest
Innovation, investment in pain and addiction are not meeting the societal burden, report says
With nearly all experimental pain and addiction drugs failing to make it out of the clinic over the past five years, it’s not hard to see why pharma has been resistant to drug development in this area. A new report from the Biotechnology Innovation Organization (BIO)...
New BIO Analysis Reveals Declining Pain Drug Pipeline and Underinvestment in New Addiction Therapies
Today, the Biotechnology Innovation Organization (BIO) released a new analysis showing that the current level of investment in new pain and addiction treatments is falling short of what is needed to combat the mounting public health crises. The report, authored by...
WisBusiness: the Podcast with Alex Vodenlich, Plumb Pharmaceuticals
WisBusiness: the Podcast with Alex Vodenlich, Plumb Pharmaceuticals December 15, 2022 This week’s episode of “WisBusiness: the Podcast” is with Alex Vodenlich, president and CEO of Plumb Pharmaceuticals. This Madison-based company recently landed a $500,000...
Plumb Pharmaceuticals, Inc. Announces Seed Financing
New website launched: plumbpharma.com MADISON, Wis., December 01, 2022 – Earlier this year Plumb Pharmaceuticals, Inc. secured investment from the Winnow Fund, a Madison-based venture capital fund investing in pre-seed Wisconsin-headquartered startups with a...
Now Hiring: Pharmaceutical Formulations Scientist
About the Position Plumb Pharmaceuticals, Inc., an exciting start-up with several drug delivery patents is looking for an experienced formulation scientist to conduct activities related to formulation development under research and development settings. Our...